Stockreport

Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q4 2023 Earnings Call Transcript [Yahoo! Finance]

Inovio Pharmaceuticals, Inc.  (INO) 
NASDAQ:AMEX Investor Relations: ir.inovio.com/investors/default.aspx
PDF Reported EPS is $-1.12, expectations were $-1.58. Inovio Pharmaceuticals, Inc. isn't one of the 30 most popular stocks among hedge funds at the end of the third quarter [Read more]